Industry Focus

Marijuana stocks OrganiGram and Aphria reported quarterly earnings this week - here's what you should know. Also, Abbott locks horns with DexCom in diabetes and what's next for Bristol-Myers' now that its Celgene acquisition is official.

Check out more of our content here:

Direct download: 20190417_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EDT